You have 9 free searches left this month | for more free features.

1 alpha-hydroxyergocalciferol

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)

Recruiting
  • Alpha-1 Antitrypsin Deficiency
  • Alpha-1 Antitrypsin Genotype
  • Gainesville, Florida
    University of Florida
Nov 2, 2022

Alpha 1-Antitrypsin Deficiency Trial in Charleston (KB408 (Nebulization))

Not yet recruiting
  • Alpha 1-Antitrypsin Deficiency
  • KB408 (Nebulization)
  • Charleston, South Carolina
    Medical University of South Carolina
Sep 20, 2023

Alpha-1 Antitrypsin Deficiency Trial in San Diego, Boston, Saint Louis (Liver Biopsy (Biopsy Group Only))

Recruiting
  • Alpha-1 Antitrypsin Deficiency
  • Liver Biopsy (Biopsy Group Only)
  • San Diego, California
  • +2 more
Dec 13, 2022

DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)

Not yet recruiting
  • Diabetes MellitusType 1
  • Placebo
  • Alpha Lipoic Acid 600 MG Oral Capsule
  • (no location specified)
Jan 8, 2023

Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))

Recruiting
  • Alpha1-Antitrypsin Deficiency
  • Alpha-1 15%
  • Liquid Alpha1-Proteinase Inhibitor (Human)
  • Gainesville, Florida
  • +5 more
Jan 13, 2023

Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection)

Not yet recruiting
  • Alpha1-Antitrypsin Deficiency
  • Fazirsiran Injection
  • (no location specified)
Jun 16, 2023

Alpha-1 Foundation DNA and Tissue Bank

Enrolling by invitation
  • Alpha 1 Antitrypsin Deficiency
    • Gainesville, Florida
      University of Florida
    Sep 19, 2022

    Cardiac Functions in Type 1 Diabetes Mellitus

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • transthoracic echocardiography
    • (no location specified)
    Nov 12, 2023

    Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )

    Recruiting
    • Type1diabetes
    • +2 more
    • Infusion of GIP[1-42], GIP[1-30] or placebo
    • Hellerup, Copenhagen, Denmark
      Center for Clinical Metabolic Research, Gentofte Hospital
    Nov 17, 2023

    Bronchiectasis Adult Trial in Dundee (Alpha 1-Proteinase Inhibitor 180mg/kg, Alpha 1-Proteinase Inhibitor 120mg/kg, Sodium

    Not yet recruiting
    • Bronchiectasis Adult
    • Alpha 1-Proteinase Inhibitor 180mg/kg
    • +2 more
    • Dundee, United Kingdom
      NHS Tayside
    Oct 12, 2022

    NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

    Recruiting
    • Non-small Cell Lung Cancer
    • Hypofractionated radiotherapy
    • +4 more
    • Guangzhou, Guangdong, China
      Sun yat-sen university cancer center
    Nov 14, 2023

    COPD Exacerbation Blood and Urine Biomarkers Study

    Recruiting
    • Chronic Obstructive Pulmonary Disease
    • +2 more
      • New York, New York
        Columbia University Medical Center
      Oct 11, 2022

      HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

      Recruiting
      • HLA-A2 Positive Cells Present
      • Refractory Melanoma
      • Alpha-type-1 Polarized Dendritic Cells
      • +5 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Dec 12, 2022

      Intrauterine Growth Restriction in Pre-eclamptic Women

      Not yet recruiting
      • alpha1 Anti-trypsin
      • +2 more
      • Alpha1 -Antitrypsin level
      • (no location specified)
      Nov 18, 2022

      COPD (COPD), Alpha1-Antitrypsin Deficiency Trial (ARALAST NP, Another Available A1PI)

      Not yet recruiting
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Alpha1-Antitrypsin Deficiency
      • ARALAST NP
      • Another Available A1PI
      • (no location specified)
      Jul 18, 2022

      Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

      Completed
      • Alpha 1-Antitrypsin Deficiency
      • ADVM-043
      • Gainesville, Florida
      • +1 more
      Aug 3, 2022

      Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection, Placebo)

      Not yet recruiting
      • Alpha1-Antitrypsin Deficiency
      • Fazirsiran Injection
      • Placebo
      • (no location specified)
      Feb 2, 2023

      Coronary Artery Disease Trial in United Kingdom (BioMatrix Alpha)

      Not yet recruiting
      • Coronary Artery Disease
      • BioMatrix Alpha
      • Birmingham, United Kingdom
      • +5 more
      Mar 23, 2023

      Alpha1-Antitrypsin Deficiency Trial in Aomori, Hokkaido, Tokyo (Alpha-1 MP)

      Completed
      • Alpha1-Antitrypsin Deficiency
      • Alpha-1 MP
      • Aomori, Japan
      • +2 more
      Mar 22, 2022

      Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

      Not yet recruiting
      • Anatomic Stage IV Breast Cancer AJCC v8
      • +2 more
      • Biopsy
      • +7 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Feb 23, 2023

      Eosinophilic Esophagitis Trial (Alpha-proteinase inhibitor)

      Not yet recruiting
      • Eosinophilic Esophagitis
      • Alpha-proteinase inhibitor
      • (no location specified)
      Aug 2, 2022

      Type 1 Diabetes Trial in Edmonton (Alpha-1 Antitrypsin)

      Completed
      • Type 1 Diabetes Mellitus
      • Alpha-1 Antitrypsin
      • Edmonton, Alberta, Canada
        University of Alberta
      May 23, 2022

      Alpha 1-Antitrypsin Deficiency, Genetic Disease Trial in United States

      Recruiting
      • Alpha 1-Antitrypsin Deficiency
      • Genetic Disease
        • Birmingham, Alabama
        • +9 more
        Jul 4, 2022

        Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

        Not yet recruiting
        • Cytomegaloviral Infection
        • Hematopoietic and Lymphoid System Neoplasm
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +2 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        Dec 16, 2022

        Alpha-1-antitrypsin Deficiency Trial in Praha

        Recruiting
        • Alpha-1-antitrypsin Deficiency
          • Praha, Czech Republic, Czechia
            Thomayer university hospital
          Dec 16, 2021